SUSMED, Inc. Hits Day Low of JPY 955 Amid Price Pressure

SUSMED, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 9.42% to reach an intraday low of JPY 955.00. This downturn comes amidst a contrasting performance from the Japan Nikkei 225, which rose by 5.39% on the same day. Over the past week, SUSMED has seen a decrease of 6.15%, while its monthly performance reflects a decline of 6.42%. Despite these short-term challenges, the company has shown resilience over the past year, boasting a remarkable return of 102.1%, significantly outpacing the Nikkei's 70.57% gain. However, the company's financial metrics indicate underlying concerns. SUSMED has reported a negative EBITDA of Rs. -278.44 crore and a low return on equity of 0.04%, suggesting limited profitability relative to shareholder funds. The stock's performance over three years has been particularly challenging, with a decline of 26.84%, contrasting sharply with the Nikkei's impressive growth of 104.62% during the same period.